R Caballero
Overview
Explore the profile of R Caballero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de la Haba-Rodriguez J, Minguez P, Rojo F, Martin M, Alba E, Servitja S, et al.
J Mammary Gland Biol Neoplasia
. 2024 Nov;
29(1):18.
PMID: 39514034
Gestational breast cancer (GBC), defined as breast cancer (BC) diagnosed during pregnancy or the first-year post-partum, accounts for 6-15% of BC cases in women aged 20-44 years. GBC has worse...
2.
de la Cruz-Merino L, Gion M, Cruz J, Alonso-Romero J, Quiroga V, Moreno F, et al.
BMC Cancer
. 2022 Dec;
22(1):1258.
PMID: 36463104
Background: We evaluated a new chemoimmunotherapy combination based on the anti-PD1 monoclonal antibody pembrolizumab and the pyrimidine antimetabolite gemcitabine in HER2- advanced breast cancer (ABC) patients previously treated in the...
3.
Crespo-Garcia T, Camara-Checa A, Dago M, Rubio-Alarcon M, Rapun J, Tamargo J, et al.
Biochem Pharmacol
. 2022 Aug;
204:115206.
PMID: 35963339
Cardiac electrical activity is governed by different ion channels that generate action potentials. Acquired or inherited abnormalities in the expression and/or function of ion channels usually result in electrophysiological changes...
4.
Martin M, Zielinski C, Ruiz-Borrego M, Carrasco E, Turner N, Ciruelos E, et al.
Ann Oncol
. 2021 Jan;
32(4):488-499.
PMID: 33385521
Background: Palbociclib plus endocrine therapy (ET) is the standard treatment of hormone receptor-positive and human epidermal growth factor receptor 2-negative, metastatic breast cancer (MBC). However, its efficacy has not been...
5.
Lopez-Alcorocho J, Aboli L, Rodriguez-Inigo E, Guillen-Vicente I, Guillen-Vicente M, Caballero R, et al.
Rev Esp Cir Ortop Traumatol (Engl Ed)
. 2019 Jun;
63(4):253-260.
PMID: 31147299
Background: Recently, a new approach of autologous chondrocyte implantation technique (using as biomaterial a collagen type i/iii membrane) based on increasing cell density called HD-ACI (High Density Autologous Chondrocyte Implantation)...
6.
Templeton A, Rodriguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, et al.
Clin Transl Oncol
. 2018 May;
20(12):1548-1556.
PMID: 29766456
Purpose: Elevated markers of host inflammation, a hallmark of cancer, have been associated with worse outcomes in several solid tumors. Here, we explore the prognostic role of the derived neutrophil-to-lymphocyte...
7.
Ethier J, Ocana A, Rodriguez Lescure A, Ruiz A, Alba E, Calvo L, et al.
Eur J Cancer
. 2018 Mar;
94:199-205.
PMID: 29573665
Background: Retrospective data suggest better outcomes for patients with double hormonal receptor (oestrogen [ER] and progesterone receptor [PgR])-positive (dHR+) early breast cancer, compared with single hormonal receptor-positive, sHR+, (ER+/PgR- or...
8.
Purcell C, Batke S, Yiotis C, Caballero R, Soh W, Murray M, et al.
Ann Bot
. 2018 Feb;
121(7):1427.
PMID: 29471375
No abstract available.
9.
Purcell C, Batke S, Yiotis C, Caballero R, Soh W, Murray M, et al.
Ann Bot
. 2018 Feb;
121(6):1137-1149.
PMID: 29394303
Background And Aims: Studies have indicated that plant stomatal conductance (gs) decreases in response to elevated atmospheric CO2, a phenomenon of significance for the global hydrological cycle. However, gs increases...
10.
de la Cruz-Merino L, Chiesa M, Caballero R, Rojo F, Palazon N, Carrasco F, et al.
Int Rev Cell Mol Biol
. 2017 Mar;
331:1-53.
PMID: 28325210
Cancer immunology has gained renewed interest in the past few years due to emerging findings on mechanisms involved in tumoral immune evasion. Indisputably, immune edition is currently considered a critical...